Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Mortality in patients with schizophrenia.

Dervaux A, Laqueille X.

Lancet. 2009 Nov 7;374(9701):1592; author reply 1592-3. doi: 10.1016/S0140-6736(09)61944-9. No abstract available.

PMID:
19897120
2.

Mortality in patients with schizophrenia.

Sperling W, Biermann T.

Lancet. 2009 Nov 7;374(9701):1592; author reply 1592-3. doi: 10.1016/S0140-6736(09)61943-7. No abstract available.

PMID:
19897121
3.

Mortality in patients with schizophrenia.

Basu D, Aggarwal M.

Lancet. 2009 Nov 7;374(9701):1591; author reply 1592-3. doi: 10.1016/S0140-6736(09)61941-3. No abstract available.

PMID:
19897117
4.

Substance abuse in clozapine-treated schizophrenic patients.

Sand PG, Soyka M.

J Neuropsychiatry Clin Neurosci. 1997 Fall;9(4):626-7. No abstract available.

PMID:
9447510
5.
6.

Clozapine and suicide.

Sernyak MJ, Hoff R, Rosenheck R.

Psychiatr Serv. 1999 Jan;50(1):116-7. No abstract available.

PMID:
9890596
7.

Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain.

Haasen C, Lambert M, Yagdiran O, Karow A, Krausz M, Naber D.

Int Clin Psychopharmacol. 2003 Mar;18(2):113-5.

PMID:
12598824
8.

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia.

Drake RE, Xie H, McHugo GJ, Green AI.

Schizophr Bull. 2000;26(2):441-9.

PMID:
10885642
9.
10.

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J.

Lancet. 2009 Aug 22;374(9690):620-7. doi: 10.1016/S0140-6736(09)60742-X.

PMID:
19595447
11.

Substance abuse in schizophrenia: a review.

Buckley PF.

J Clin Psychiatry. 1998;59 Suppl 3:26-30. Review.

12.

Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse.

Voruganti LN, Heslegrave RJ, Awad AG.

J Nerv Ment Dis. 1997 Jul;185(7):463-5. No abstract available.

PMID:
9240366
13.

Mortality in current and former users of clozapine.

Walker AM, Lanza LL, Arellano F, Rothman KJ.

Epidemiology. 1997 Nov;8(6):671-7.

PMID:
9345668
14.

Predictors of clozapine discontinuation in patients with schizophrenia.

Krivoy A, Malka L, Fischel T, Weizman A, Valevski A.

Int Clin Psychopharmacol. 2011 Nov;26(6):311-5. doi: 10.1097/YIC.0b013e32834ab34c.

PMID:
21849905
15.

Mortality risk and clozapine.

Clardy J, Gale RH.

Am J Psychiatry. 1995 Apr;152(4):651. No abstract available.

PMID:
7694929
16.

Effect of clozapine on mortality.

Howes O, Ohlsen R, Pilowsky LS.

Br J Psychiatry. 2003 Nov;183:460. No abstract available.

17.

Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study.

Kelly DL, McMahon RP, Liu F, Love RC, Wehring HJ, Shim JC, Warren KR, Conley RR.

J Clin Psychiatry. 2010 Mar;71(3):304-11. doi: 10.4088/JCP.08m04718yel. Epub 2010 Jan 12.

18.

Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.

Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC.

J Clin Psychiatry. 2005 Sep;66(9):1116-21.

PMID:
16187768
19.

Mortality in patients with schizophrenia.

De Hert M, Peuskens J, van Winkel R.

Lancet. 2009 Nov 7;374(9701):1591; author reply 1592-3. doi: 10.1016/S0140-6736(09)61942-5. No abstract available.

PMID:
19897118
20.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369

Supplemental Content

Support Center